{
 "as_of": "2026-11-06",
 "cmr": "uk-cm-kg/LSE/RTW",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# RTW BIOTECH OPPORTUNITIES LTD (LSE Main Market: RTW) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is RTW BIOTECH OPPORTUNITIES LTD, listed on the LSE Main Market under ticker RTW, ISIN GG00BKTRRM22, LEI 549300Q7EXQQH6KF7Z84. Its security type is Fund (FUND), segment STMM, sector Closed End Investments [302040], jurisdiction Guernsey (GG). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 0 filings in the window 2025-11-06 to 2026-11-06, on 0 filing days. The median gap between filing days is not on the record. The latest filing date is not on the record, and so is the days from latest filing to record date (2026-11-06). The LSE Main Market peers have a median cadence gap of 4 days, a median of 29.0 filings, and a median latency of 3 days across 892 issuers. The sector peers, Closed End Investments [302040], have a median cadence gap of 5.5 days, a median of 0 filings, and a median latency of 4.5 days across 269 issuers. The issuer's latest filing type is not on the record.\n\n## Auditor\n\nThe auditor is not on the record, as the record was not searched for this security type (fund, receipt or debt security). The auditor location is not on the record. Auditor changes are not on the record, as the market's record carries no lifecycle type map for this register yet.\n\n## Events and halts\n\nThe listing, delisting, name change, domicile change and segment move lines are not on the record, as the market's record carries no lifecycle type map for this register yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nThe elective professional client outcome is ACM-200, determinable. The eligible counterparty outcome is ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page; the count is 0.\n\n## Open research\n\nThe record holds 3 openly published research notes. Edison Investment Research published on 2023-11-01, on 2023-07-05 and on 2022-01-11.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed on the record. The live record began on 2026-09-11. The years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.\n\n## Sources\n\n12 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/RTW (identity.isin)\n- https://api.gleif.org/api/v1/lei-records/549300Q7EXQQH6KF7Z84 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/RTW/rtw-biotech-opportunities-ltd/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/LSE/RTW (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.edisongroup.com/research/significant-acquisition-of-arix-bioscienceas-assets/32844/ (open research)\n- https://www.edisongroup.com/research/use-of-prometheus-biosciences-sale-proceeds/32480/ (open research)\n- https://www.edisongroup.com/research/one-stop-shop-for-biotech-lifecycle-investment/30382/ (open research)\n- https://mcp.uk-cm-kg.ai/record/LSE/RTW (the record)\n",
 "market": "UK",
 "node": "uk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-11",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "market": "UK",
    "reason": "not searched (fund/receipt/debt security)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "UK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "UK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "uk-cm-kg/LSE/RTW",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://www.rtwfunds.com/rtw-biotech-opportunities-ltd/research/",
     "result": "not readable by this rail (403)"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 892,
     "median_cadence_gap_days": 4,
     "median_filings": 29,
     "median_latency_days": 3,
     "name": "LSE Main Market"
    },
    "sector": {
     "issuers": 269,
     "median_cadence_gap_days": 5.5,
     "median_filings": 0,
     "median_latency_days": 4.5,
     "name": "Closed End Investments [302040]"
    }
   },
   "by_type": {},
   "cadence_median_gap_days": null,
   "filing_days": 0,
   "filings": 0,
   "latency_days": null,
   "latest": [],
   "latest_filing_date": null,
   "note": "no disclosure line on the record for this issuer in the window",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/RTW",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "LSE Main Market"
   },
   "isin": {
    "read_by": "LSE instrument reference record (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/RTW",
    "state": "sourced",
    "value": "GG00BKTRRM22"
   },
   "jurisdiction": {
    "read_by": "GLEIF LEI record (LEI per the LEI column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/549300Q7EXQQH6KF7Z84",
    "state": "sourced",
    "value": "Guernsey (GG)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN GG00BKTRRM22)",
    "state": "sourced",
    "value": "549300Q7EXQQH6KF7Z84"
   },
   "name": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "RTW BIOTECH OPPORTUNITIES LTD"
   },
   "sector": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/RTW/rtw-biotech-opportunities-ltd/company-page",
    "state": "sourced",
    "value": "Closed End Investments [302040]"
   },
   "security_type": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "Fund (FUND)"
   },
   "segment": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "STMM"
   },
   "ticker": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "RTW"
   },
   "website": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/RTW/rtw-biotech-opportunities-ltd/company-page",
    "state": "sourced",
    "value": "https://url.uk.m.mimecastprotect.com/s/GmLlCE0XvhnLvVlpiwJj15?domain=rtwfunds.com"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "UK",
  "node": "uk-cm-kg",
  "numbers_hash": "sha256:75d4d969b5bf64a18c7a74bbe7561d24c77915d2fb6bae082cf4202fff58eba5",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2023-11-01",
     "kind": "issuer-sponsored",
     "publisher": "Edison Investment Research",
     "read_by": "the note's own page, fetched by this rail",
     "read_date": "2026-11-12",
     "source": "https://www.edisongroup.com/research/significant-acquisition-of-arix-bioscienceas-assets/32844/",
     "state": "sourced",
     "title": "RTW Biotech Opportunities – Significant acquisition of Arix Bioscience’s assets"
    },
    {
     "date": "2023-07-05",
     "kind": "issuer-sponsored",
     "publisher": "Edison Investment Research",
     "read_by": "the note's own page, fetched by this rail",
     "read_date": "2026-11-12",
     "source": "https://www.edisongroup.com/research/use-of-prometheus-biosciences-sale-proceeds/32480/",
     "state": "sourced",
     "title": "RTW Biotech Opportunities — Use of Prometheus Biosciences' sale proceeds"
    },
    {
     "date": "2022-01-11",
     "kind": "issuer-sponsored",
     "publisher": "Edison Investment Research",
     "read_by": "the note's own page, fetched by this rail",
     "read_date": "2026-11-12",
     "source": "https://www.edisongroup.com/research/one-stop-shop-for-biotech-lifecycle-investment/30382/",
     "state": "sourced",
     "title": "RTW Venture Fund Limited — 'One-stop shop' for biotech lifecycle investment"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "elective professional client",
    "eligible counterparty"
   ],
   "outcomes": {
    "elective professional client": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "eligible counterparty": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.uk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1",
   "section": "uk.aio.v16"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.uk-cm-kg.ai/record/LSE/RTW",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://marketsecurities.fca.org.uk/officiallist",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:75d4d969b5bf64a18c7a74bbe7561d24c77915d2fb6bae082cf4202fff58eba5",
 "path": "/uk/LSE/RTW",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is RTW BIOTECH OPPORTUNITIES LTD, listed on the LSE Main Market under ticker RTW, ISIN GG00BKTRRM22, LEI 549300Q7EXQQH6KF7Z84. Its security type is Fund (FUND), segment STMM, sector Closed End Investments [302040], jurisdiction Guernsey (GG). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 0 filings in the window 2025-11-06 to 2026-11-06, on 0 filing days. The median gap between filing days is not on the record. The latest filing date is not on the record, and so is the days from latest filing to record date (2026-11-06). The LSE Main Market peers have a median cadence gap of 4 days, a median of 29.0 filings, and a median latency of 3 days across 892 issuers. The sector peers, Closed End Investments [302040], have a median cadence gap of 5.5 days, a median of 0 filings, and a median latency of 4.5 days across 269 issuers. The issuer's latest filing type is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record, as the record was not searched for this security type (fund, receipt or debt security). The auditor location is not on the record. Auditor changes are not on the record, as the market's record carries no lifecycle type map for this register yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The listing, delisting, name change, domicile change and segment move lines are not on the record, as the market's record carries no lifecycle type map for this register yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The elective professional client outcome is ACM-200, determinable. The eligible counterparty outcome is ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page; the count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 3 openly published research notes. Edison Investment Research published on 2023-11-01, on 2023-07-05 and on 2022-01-11.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed on the record. The live record began on 2026-09-11. The years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "12 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer"
  },
  {
   "for": "identity.isin",
   "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/RTW"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://api.gleif.org/api/v1/lei-records/549300Q7EXQQH6KF7Z84"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "identity.sector",
   "source": "https://www.londonstockexchange.com/stock/RTW/rtw-biotech-opportunities-ltd/company-page"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/RTW"
  },
  {
   "for": "the halt flag",
   "source": "https://marketsecurities.fca.org.uk/officiallist"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.uk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "open research",
   "source": "https://www.edisongroup.com/research/significant-acquisition-of-arix-bioscienceas-assets/32844/"
  },
  {
   "for": "open research",
   "source": "https://www.edisongroup.com/research/use-of-prometheus-biosciences-sale-proceeds/32480/"
  },
  {
   "for": "open research",
   "source": "https://www.edisongroup.com/research/one-stop-shop-for-biotech-lifecycle-investment/30382/"
  },
  {
   "for": "the record",
   "source": "https://mcp.uk-cm-kg.ai/record/LSE/RTW"
  }
 ],
 "title": "RTW BIOTECH OPPORTUNITIES LTD (RTW) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}